Global Androgen Antagonist Market Growth (Status and Outlook) 2024-2030

May 2024 | 109 pages | ID: GFF593575386EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Androgen Antagonist market size is projected to grow from US$ 6622.8 million in 2023 to US$ 9833.4 million in 2030; it is expected to grow at a CAGR of 5.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Androgen Antagonist Industry Forecast” looks at past sales and reviews total world Androgen Antagonist sales in 2023, providing a comprehensive analysis by region and market sector of projected Androgen Antagonist sales for 2024 through 2030. With Androgen Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androgen Antagonist industry.

This Insight Report provides a comprehensive analysis of the global Androgen Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androgen Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androgen Antagonist market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androgen Antagonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androgen Antagonist.

United States market for Androgen Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Androgen Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Androgen Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Androgen Antagonist players cover Pfizer, Johnson & Johnson, AstraZeneca, Astellas and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Antagonist market by product type, application, key players and key regions and countries.

Segmentation by type

• Steroidal Androgen Antagonist
• Nonsteroidal Androgen Antagonist

Segmentation by application

• Prostate Cancer
• Benign Prostatic Hyperplasia
• Polycystic Ovary Syndrome (POCS)
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Merck
• Sanofi
• Orion Corporation
• Hengrui
• Bayer
• Schering-Plough
• Hinova Pharma
• Jiangsu Hengrui Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Androgen Antagonist Market Size 2019-2030
  2.1.2 Androgen Antagonist Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Androgen Antagonist Segment by Type
  2.2.1 Steroidal Androgen Antagonist
  2.2.2 Nonsteroidal Androgen Antagonist
2.3 Androgen Antagonist Market Size by Type
  2.3.1 Androgen Antagonist Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Androgen Antagonist Market Size Market Share by Type (2019-2024)
2.4 Androgen Antagonist Segment by Application
  2.4.1 Prostate Cancer
  2.4.2 Benign Prostatic Hyperplasia
  2.4.3 Polycystic Ovary Syndrome (POCS)
  2.4.4 Others
2.5 Androgen Antagonist Market Size by Application
  2.5.1 Androgen Antagonist Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Androgen Antagonist Market Size Market Share by Application (2019-2024)

3 ANDROGEN ANTAGONIST MARKET SIZE BY PLAYER

3.1 Androgen Antagonist Market Size Market Share by Players
  3.1.1 Global Androgen Antagonist Revenue by Players (2019-2024)
  3.1.2 Global Androgen Antagonist Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Antagonist Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANDROGEN ANTAGONIST BY REGIONS

4.1 Androgen Antagonist Market Size by Regions (2019-2024)
4.2 Americas Androgen Antagonist Market Size Growth (2019-2024)
4.3 APAC Androgen Antagonist Market Size Growth (2019-2024)
4.4 Europe Androgen Antagonist Market Size Growth (2019-2024)
4.5 Middle East & Africa Androgen Antagonist Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Androgen Antagonist Market Size by Country (2019-2024)
5.2 Americas Androgen Antagonist Market Size by Type (2019-2024)
5.3 Americas Androgen Antagonist Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Androgen Antagonist Market Size by Region (2019-2024)
6.2 APAC Androgen Antagonist Market Size by Type (2019-2024)
6.3 APAC Androgen Antagonist Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Androgen Antagonist by Country (2019-2024)
7.2 Europe Androgen Antagonist Market Size by Type (2019-2024)
7.3 Europe Androgen Antagonist Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Androgen Antagonist by Region (2019-2024)
8.2 Middle East & Africa Androgen Antagonist Market Size by Type (2019-2024)
8.3 Middle East & Africa Androgen Antagonist Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANDROGEN ANTAGONIST MARKET FORECAST

10.1 Global Androgen Antagonist Forecast by Regions (2025-2030)
  10.1.1 Global Androgen Antagonist Forecast by Regions (2025-2030)
  10.1.2 Americas Androgen Antagonist Forecast
  10.1.3 APAC Androgen Antagonist Forecast
  10.1.4 Europe Androgen Antagonist Forecast
  10.1.5 Middle East & Africa Androgen Antagonist Forecast
10.2 Americas Androgen Antagonist Forecast by Country (2025-2030)
  10.2.1 United States Androgen Antagonist Market Forecast
  10.2.2 Canada Androgen Antagonist Market Forecast
  10.2.3 Mexico Androgen Antagonist Market Forecast
  10.2.4 Brazil Androgen Antagonist Market Forecast
10.3 APAC Androgen Antagonist Forecast by Region (2025-2030)
  10.3.1 China Androgen Antagonist Market Forecast
  10.3.2 Japan Androgen Antagonist Market Forecast
  10.3.3 Korea Androgen Antagonist Market Forecast
  10.3.4 Southeast Asia Androgen Antagonist Market Forecast
  10.3.5 India Androgen Antagonist Market Forecast
  10.3.6 Australia Androgen Antagonist Market Forecast
10.4 Europe Androgen Antagonist Forecast by Country (2025-2030)
  10.4.1 Germany Androgen Antagonist Market Forecast
  10.4.2 France Androgen Antagonist Market Forecast
  10.4.3 UK Androgen Antagonist Market Forecast
  10.4.4 Italy Androgen Antagonist Market Forecast
  10.4.5 Russia Androgen Antagonist Market Forecast
10.5 Middle East & Africa Androgen Antagonist Forecast by Region (2025-2030)
  10.5.1 Egypt Androgen Antagonist Market Forecast
  10.5.2 South Africa Androgen Antagonist Market Forecast
  10.5.3 Israel Androgen Antagonist Market Forecast
  10.5.4 Turkey Androgen Antagonist Market Forecast
  10.5.5 GCC Countries Androgen Antagonist Market Forecast
10.6 Global Androgen Antagonist Forecast by Type (2025-2030)
10.7 Global Androgen Antagonist Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Androgen Antagonist Product Offered
  11.1.3 Pfizer Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Androgen Antagonist Product Offered
  11.2.3 Johnson & Johnson Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Information
  11.3.2 AstraZeneca Androgen Antagonist Product Offered
  11.3.3 AstraZeneca Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca Latest Developments
11.4 Astellas
  11.4.1 Astellas Company Information
  11.4.2 Astellas Androgen Antagonist Product Offered
  11.4.3 Astellas Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Astellas Main Business Overview
  11.4.5 Astellas Latest Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Androgen Antagonist Product Offered
  11.5.3 Merck Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Merck Main Business Overview
  11.5.5 Merck Latest Developments
11.6 Sanofi
  11.6.1 Sanofi Company Information
  11.6.2 Sanofi Androgen Antagonist Product Offered
  11.6.3 Sanofi Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Sanofi Main Business Overview
  11.6.5 Sanofi Latest Developments
11.7 Orion Corporation
  11.7.1 Orion Corporation Company Information
  11.7.2 Orion Corporation Androgen Antagonist Product Offered
  11.7.3 Orion Corporation Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Orion Corporation Main Business Overview
  11.7.5 Orion Corporation Latest Developments
11.8 Hengrui
  11.8.1 Hengrui Company Information
  11.8.2 Hengrui Androgen Antagonist Product Offered
  11.8.3 Hengrui Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Hengrui Main Business Overview
  11.8.5 Hengrui Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer Androgen Antagonist Product Offered
  11.9.3 Bayer Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 Schering-Plough
  11.10.1 Schering-Plough Company Information
  11.10.2 Schering-Plough Androgen Antagonist Product Offered
  11.10.3 Schering-Plough Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Schering-Plough Main Business Overview
  11.10.5 Schering-Plough Latest Developments
11.11 Hinova Pharma
  11.11.1 Hinova Pharma Company Information
  11.11.2 Hinova Pharma Androgen Antagonist Product Offered
  11.11.3 Hinova Pharma Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Hinova Pharma Main Business Overview
  11.11.5 Hinova Pharma Latest Developments
11.12 Jiangsu Hengrui Pharmaceuticals
  11.12.1 Jiangsu Hengrui Pharmaceuticals Company Information
  11.12.2 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Product Offered
  11.12.3 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
  11.12.5 Jiangsu Hengrui Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Androgen Antagonist Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Steroidal Androgen Antagonist
Table 3. Major Players of Nonsteroidal Androgen Antagonist
Table 4. Androgen Antagonist Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Androgen Antagonist Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Androgen Antagonist Market Size Market Share by Type (2019-2024)
Table 7. Androgen Antagonist Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Androgen Antagonist Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Androgen Antagonist Market Size Market Share by Application (2019-2024)
Table 10. Global Androgen Antagonist Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Androgen Antagonist Revenue Market Share by Player (2019-2024)
Table 12. Androgen Antagonist Key Players Head office and Products Offered
Table 13. Androgen Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Androgen Antagonist Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Androgen Antagonist Market Size Market Share by Regions (2019-2024)
Table 18. Global Androgen Antagonist Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Androgen Antagonist Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Androgen Antagonist Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Androgen Antagonist Market Size Market Share by Country (2019-2024)
Table 22. Americas Androgen Antagonist Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Androgen Antagonist Market Size Market Share by Type (2019-2024)
Table 24. Americas Androgen Antagonist Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Androgen Antagonist Market Size Market Share by Application (2019-2024)
Table 26. APAC Androgen Antagonist Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Androgen Antagonist Market Size Market Share by Region (2019-2024)
Table 28. APAC Androgen Antagonist Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Androgen Antagonist Market Size Market Share by Type (2019-2024)
Table 30. APAC Androgen Antagonist Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Androgen Antagonist Market Size Market Share by Application (2019-2024)
Table 32. Europe Androgen Antagonist Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Androgen Antagonist Market Size Market Share by Country (2019-2024)
Table 34. Europe Androgen Antagonist Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Androgen Antagonist Market Size Market Share by Type (2019-2024)
Table 36. Europe Androgen Antagonist Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Androgen Antagonist Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Androgen Antagonist Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Androgen Antagonist Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Androgen Antagonist Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Androgen Antagonist Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Androgen Antagonist Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Androgen Antagonist Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Androgen Antagonist
Table 45. Key Market Challenges & Risks of Androgen Antagonist
Table 46. Key Industry Trends of Androgen Antagonist
Table 47. Global Androgen Antagonist Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Androgen Antagonist Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Androgen Antagonist Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Androgen Antagonist Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Pfizer Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 52. Pfizer Androgen Antagonist Product Offered
Table 53. Pfizer Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Johnson & Johnson Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 57. Johnson & Johnson Androgen Antagonist Product Offered
Table 58. Johnson & Johnson Main Business
Table 59. Johnson & Johnson Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Johnson & Johnson Latest Developments
Table 61. AstraZeneca Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 62. AstraZeneca Androgen Antagonist Product Offered
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. AstraZeneca Latest Developments
Table 66. Astellas Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 67. Astellas Androgen Antagonist Product Offered
Table 68. Astellas Main Business
Table 69. Astellas Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Astellas Latest Developments
Table 71. Merck Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 72. Merck Androgen Antagonist Product Offered
Table 73. Merck Main Business
Table 74. Merck Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Merck Latest Developments
Table 76. Sanofi Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 77. Sanofi Androgen Antagonist Product Offered
Table 78. Sanofi Main Business
Table 79. Sanofi Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Sanofi Latest Developments
Table 81. Orion Corporation Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 82. Orion Corporation Androgen Antagonist Product Offered
Table 83. Orion Corporation Main Business
Table 84. Orion Corporation Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Orion Corporation Latest Developments
Table 86. Hengrui Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 87. Hengrui Androgen Antagonist Product Offered
Table 88. Hengrui Main Business
Table 89. Hengrui Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hengrui Latest Developments
Table 91. Bayer Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 92. Bayer Androgen Antagonist Product Offered
Table 93. Bayer Main Business
Table 94. Bayer Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Bayer Latest Developments
Table 96. Schering-Plough Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 97. Schering-Plough Androgen Antagonist Product Offered
Table 98. Schering-Plough Main Business
Table 99. Schering-Plough Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Schering-Plough Latest Developments
Table 101. Hinova Pharma Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 102. Hinova Pharma Androgen Antagonist Product Offered
Table 103. Hinova Pharma Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Hinova Pharma Main Business
Table 105. Hinova Pharma Latest Developments
Table 106. Jiangsu Hengrui Pharmaceuticals Details, Company Type, Androgen Antagonist Area Served and Its Competitors
Table 107. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Product Offered
Table 108. Jiangsu Hengrui Pharmaceuticals Main Business
Table 109. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Jiangsu Hengrui Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Androgen Antagonist Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Androgen Antagonist Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Androgen Antagonist Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Androgen Antagonist Sales Market Share by Country/Region (2023)
Figure 8. Androgen Antagonist Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Androgen Antagonist Market Size Market Share by Type in 2023
Figure 10. Androgen Antagonist in Prostate Cancer
Figure 11. Global Androgen Antagonist Market: Prostate Cancer (2019-2024) & ($ Millions)
Figure 12. Androgen Antagonist in Benign Prostatic Hyperplasia
Figure 13. Global Androgen Antagonist Market: Benign Prostatic Hyperplasia (2019-2024) & ($ Millions)
Figure 14. Androgen Antagonist in Polycystic Ovary Syndrome (POCS)
Figure 15. Global Androgen Antagonist Market: Polycystic Ovary Syndrome (POCS) (2019-2024) & ($ Millions)
Figure 16. Androgen Antagonist in Others
Figure 17. Global Androgen Antagonist Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Androgen Antagonist Market Size Market Share by Application in 2023
Figure 19. Global Androgen Antagonist Revenue Market Share by Player in 2023
Figure 20. Global Androgen Antagonist Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Androgen Antagonist Market Size 2019-2024 ($ Millions)
Figure 22. APAC Androgen Antagonist Market Size 2019-2024 ($ Millions)
Figure 23. Europe Androgen Antagonist Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Androgen Antagonist Market Size 2019-2024 ($ Millions)
Figure 25. Americas Androgen Antagonist Value Market Share by Country in 2023
Figure 26. United States Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Androgen Antagonist Market Size Market Share by Region in 2023
Figure 31. APAC Androgen Antagonist Market Size Market Share by Type in 2023
Figure 32. APAC Androgen Antagonist Market Size Market Share by Application in 2023
Figure 33. China Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Androgen Antagonist Market Size Market Share by Country in 2023
Figure 40. Europe Androgen Antagonist Market Size Market Share by Type (2019-2024)
Figure 41. Europe Androgen Antagonist Market Size Market Share by Application (2019-2024)
Figure 42. Germany Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Androgen Antagonist Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Androgen Antagonist Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Androgen Antagonist Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Androgen Antagonist Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 56. APAC Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 57. Europe Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 59. United States Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 60. Canada Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 63. China Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 64. Japan Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 65. Korea Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 67. India Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 68. Australia Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 69. Germany Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 70. France Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 71. UK Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 72. Italy Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 73. Russia Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 74. Spain Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 77. Israel Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Androgen Antagonist Market Size 2025-2030 ($ Millions)
Figure 80. Global Androgen Antagonist Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Androgen Antagonist Market Size Market Share Forecast by Application (2025-2030)